Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Nov 15, 2021 · 10-Q · 46 days after period end · 0001568276-21-002533
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | $3.80M | -$2.22M | $2.22M | $1.54M |
| EPS Diluted | -$0.15 | -$0.18 | -$0.33 | -$1.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
